TCF3 and prostate carcinoma: Patel et al. [27] had suggested that silencing of TCF-3 contributed to the decrease in the proliferation of prostate cancer cells, and interestingly, the number of cells in the G1-phase significantly increased, whereas the cells in G2-phase decreased, which demonstrated the cell cycle arrest of cancer cells was induced and the proliferation was regressed.